HQYHealthEquity, Inc.

$92.62-1.2% 1Y

Is it safe?

Good

Strong, no red flags: a safe balance sheet, clean books, and quality strong.

4 good, 2 neutral
SurvivalSafe zone

Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Honest booksLow risk

Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).

Quality9 / 9

High fundamental quality Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.

Insider conviction-$1.0M

Insiders were net sellers (-$1.0M, 90 days to Oct 8, 2026), selling is often routine.

Credit gradeAAderived · Jul 31, 2026

Rock-solid balance sheet, low leverage. A rule of thumb on leverage, not a credit rating.

Drawdown risk38% volderived · Oct 9, 2026

Moderate price swings, typical volatility. Worst drawdown -61% · now 13% below its 52-week high.

Unless marked, from SEC EDGAR, as of Jan 31, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitymiddle of the market
Max drawdownmiddle of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can HQY take a bad year?

HealthEquity, Inc. carries $675M of net debt at 1.57× EBITDA: a load its earnings can carry.

$675M

Net debt · as at Q2 2027 · under two and a half years of EBITDA, comfortable

Net debt / EBITDA
1.57×

Net debt / EBITDA · 2.24× a year ago · the load is coming down

Altman Z-score
4.21

Altman Z-score · safe zone, above 3

Interest cover
6.69×

Interest cover · operating profit covers the interest bill several times over

Details›
Total debtQ2 2027
$931M
Cash and short-term investments
$256M
Net debt
$675M
EBITDA, trailing twelve months
$429M
Operating profit, trailing twelve months
$351M
Debt / equity
0.47×
Total debt / EBITDA
2.17×
Annualised volatilitytwo years of daily moves
38%
Worst drawdown on file
−61%
Below its 52-week high
13%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.